scispace - formally typeset
S

Srikanta Dash

Researcher at Tulane University

Publications -  169
Citations -  10323

Srikanta Dash is an academic researcher from Tulane University. The author has contributed to research in topics: Hepatitis C virus & Interferon. The author has an hindex of 35, co-authored 165 publications receiving 8588 citations. Previous affiliations of Srikanta Dash include All India Institute of Medical Sciences & University Medical Center New Orleans.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.

Lili Bao, +5 more
- 01 Jun 2012 - 
TL;DR: Results suggest that miR-298 directly modulates P-gp expression and is associated with the chemoresistant mechanisms of metastatic human breast cancer, which has diagnostic and therapeutic potential for predicting doxorubicin chemoresistance in human breast cancers.
Journal ArticleDOI

Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins.

Robert F. Garry, +1 more
- 15 Mar 2003 - 
TL;DR: Proteomics computational analyses suggest that hepatitis C virus (HCV) envelope glycoprotein E1 and pestivirus envelope glyCoprotein E2 are truncated class II fusion proteins.
Journal ArticleDOI

Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model.

Lili Bao, +6 more
- 01 Feb 2011 - 
TL;DR: Results indicate that doxorubicin is localized exclusively in the cytoplasm of resistant 4T1 breast cancer cells and that it cannot reach the nucleus because of increased nuclear expression of P-glycoprotein.